Advance Auto Parts, Inc. vs Abbott Laboratories — how do they compare? Advance Auto Parts, Inc. trades at $52.95 (market cap $3.19B), while Abbott Laboratories trades at $109.3 (market cap $187.95B). The key difference: Abbott Laboratories is far larger — about 58.9× Advance Auto Parts, Inc.'s market cap, and Abbott Laboratories pays the higher dividend (2.32%). Which is the better fit depends on your goals.
| AAP | ABT | |
|---|---|---|
Market Cap | $3.19B | $187.95B |
Sector | Consumer Cyclical | Health |
52-Week High | $64.17 | $136.62 |
52-Week Low | $38.75 | $82.57 |
Enterprise Value | $5.47B | $214.96B |
Dividend Yield | 1.89% | 2.32% |
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
Abbott Laboratories (ABT) trades at $108.63, up 0.77% today, near its 52-week high. The stock shows a bullish technical trend with strong moving averages, though RSI indicates overbought conditions. Fundamentally, revenue grew to $44.33B in 2025 with a net income margin of 11.65%, while recent Q1 and Q2 2026 earnings beat expectations. The company maintains solid cash flow from operations of $9.57B and recently secured CE Mark for innovative dual glucose-ketone sensors, reinforcing its healthcare leadership.
Outlook remains positive with a consensus price target of $120.70, implying 11% upside, supported by 75.6% analyst buy ratings. Key risks include competitive pressures in diagnostics and macroeconomic sensitivity. The dividend yield and innovation pipeline offer stability, but investors should monitor execution on growth initiatives amid evolving market conditions.
Trailing returns across standard periods
Latest headlines on both assets
Advance Auto Parts is one of the industry's largest retailers of aftermarket automotive parts, tools, and accessories to do-it-yourself customers in North America. Advance operated 4,972 stores as of the end of 2021, in addition to servicing 1,317 independently owned Carquest stores. The company's Worldpac unit is a premier distributor of imported original-equipment parts. Advance derived 58% of its 2021 sales from commercial clients, up from 30%-40% before the General Parts deal.
Read more on AAP →Abbott manufactures and markets medical devices, adult and pediatric nutritional products, diagnostic equipment and testing kits, and branded generic drugs. Products include pacemakers, implantable cardioverter defibrillators, neuromodulation devices, coronary stents, catheters, infant formula, nutritional liquids for adults, molecular diagnostic platforms, and immunoassays and point-of-care diagnostic equipment. Abbott derives approximately 60% of sales outside the United States.
Read more on ABT →